© 2009 The Medical-Legal News
Accutane is being pulled off the market, according to Bloomberg.com of June 26.
Roche Holding AG, maker of the drug, said the move is the result of competition from generic versions of Accutane. Accutane’s patent expired in 2002.
Roche also noted that it has been “faced with high costs from personal-injury lawsuits that the company continues to defend vigorously.”
According to the story, juries have awarded about $33 million in suits involving bowel disease, an alleged side effect of taking the acne medicine.
Roche faces about 5,000 lawsuits concerning the drug, with many suits focusing on a failure to warn of side effects such as inflammatory bowel disease, birth defects and depression, according to Bloomberg.
John Mullarkey, a 20-year-old Pennsylvania man, claims Accutane-induced depression led him to kill his cheerleader girlfriend.